New Options in GLP-1 RA Therapy
These free CME/CE activities are designed for diabetes-treating clinicians, including endocrinologists, diabetologists, primary care physicians, physician assistants, nurse practitioners, nurses, certified diabetes educators, and other healthcare providers who are involved in the management of patients with T2DM.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are one of the most versatile classes of agents for treating type 2 diabetes mellitus (T2DM). Current guidelines strongly recommend GLP-1 RAs, noting that these agents offer multiple therapeutic benefits for patients, including high glycemic efficacy, a low risk of hypoglycemia, and the potential for weight loss. Some have even been shown to have cardiovascular benefits, a long-sought goal of T2DM treatment. New and emerging GLP-1 RAs provide additional options to further individualize regimens for the treatment of T2DM. Offered in a variety of formats, these engaging activities will help clinicians recognize the unique characteristics of GLP-1 RAs when making patient-centered treatment decisions.
Test your GLP-1 RA savvy with a series of 4 short, text-based clinical “snap shots.” Receive a different “SnapFact” each week that features case-based questions with supporting evidence to demonstrate how new and emerging GLP-1 RAs might be used in different clinical scenarios.
Each Snap Fact activity is certified for 0.25 hour of credit for a total of 1.0 hour of CME/CE credit for physicians, physician assistants, nurses, nurse practitioners, and certified diabetes educators.
Pressed for time but still want expert guidance on new and emerging GLP-1 RAs? This activity consists of 4 independent video modules, each focused on a different topic pertaining to new and emerging options in GLP-1 RA therapy. Case study discussions illustrate how patients with T2DM may benefit from use of these agents.
Each module is certified for 0.5 hour of credit for a total of 2.0 hours of CME/CE credit for physicians, physician assistants, nurses, nurse practitioners, and certified diabetes educators.
The perfect clinical inservice! This webinar provides a critical review of recent efficacy and safety data for new and emerging GLP-1 RAs. Hear expert perspectives regarding the anticipated roles and significance of these agents in clinical practice, and learn how patients may benefit from use of these agents through case study discussions.
This activity is certified for 1.0 hour of CME/CE credit for physicians, physician assistants, nurses, nurse practitioners, and certified diabetes educators.